Scarica l'app Stockscreener
0.6568
1.44%
0.0093
Precedente Chiudi:
$0.6475
Aprire:
$0.6876
Volume 24 ore:
504.46K
Relative Volume:
1.16
Capitalizzazione di mercato:
$13.04M
Reddito:
$1.89M
Utile/perdita netta:
$-17.92M
Rapporto P/E:
-0.0982
EPS:
-6.69
Flusso di cassa netto:
$-15.62M
1 W Prestazione:
+9.47%
1M Prestazione:
-29.29%
6M Prestazione:
-48.49%
1 anno Prestazione:
-68.12%
Intervallo 1D:
$0.6524
$0.6876
Intervallo di 1 settimana:
$0.6046
$0.6876
Portata 52W:
$0.5906
$2.24
Longeveron Inc Stock (LGVN) Company Profile
Nome
Longeveron Inc
Settore
Industria
Telefono
305-302-7158
Indirizzo
1951 NW 7TH AVENUE, MIAMI
Confronta LGVN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LGVN
Longeveron Inc
|
0.6568 | 13.81M | 1.89M | -17.92M | -15.62M | -6.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.00 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
910.34 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-06 | Iniziato | ROTH MKM | Buy |
Longeveron Inc Borsa (LGVN) Ultime notizie
Is Longeveron Inc. stock a buy in volatile marketsJuly 2025 Price Swings & Safe Swing Trade Setups - BỘ NỘI VỤ
Longeveron Inc. (LGVN) Jumps 6% in Pre-market: What’s Driving the Move? - Stocks Telegraph
Perhaps timely catching Longeveron Inc (LGVN) would be a good idea - Setenews
Longeveron Inc. (LGVN) 5.03% in After-hours: What’s Driving the Move? - Stocks Telegraph
Take off with Longeveron Inc (LGVN): Get ready for trading - Setenews
What data driven models say about Longeveron Inc.’s futureJuly 2025 Sector Moves & Reliable Breakout Forecasts - newser.com
Longeveron to present Alzheimer's treatment data at CTAD 2025 By Investing.com - Investing.com Nigeria
Longeveron to present Alzheimer’s treatment data at CTAD 2025 By Investing.com - Investing.com Australia
Will Longeveron Inc. stock remain a Wall Street favorite2025 Dividend Review & Community Shared Stock Ideas - newser.com
Longeveron to present Alzheimer’s treatment data at CTAD 2025 - Investing.com
Longeveron Laromestrocel Data in Alzheimer’s Disease Selected for Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025) - The Manila Times
Longeveron (NASDAQ: LGVN) Presenting Laromestrocel CLEAR MIND Data at CTAD 2025 - Stock Titan
Why analysts upgrade Longeveron Inc. stock2025 Biggest Moves & Real-Time Sentiment Analysis - newser.com
Visualizing Longeveron Inc. stock with heatmapsJuly 2025 Momentum & Short-Term Swing Trade Alerts - newser.com
What drives Longeveron Inc stock priceHigh Beta Stocks & Budget Friendly Investment Plans - earlytimes.in
What dividend safety score for Longeveron Inc. stockWeekly Risk Report & Entry Point Confirmation Signals - newser.com
How Longeveron Inc. stock compares to growth peersJuly 2025 Big Picture & Expert Verified Movement Alerts - Fundação Cultural do Pará
Is Longeveron Inc. stock recession proof2025 Volume Leaders & High Accuracy Investment Signals - Fundação Cultural do Pará
Longeveron Faces Nasdaq Delisting Notice for Stock Price - MSN
Will Longeveron Inc. stock continue dividend increasesPortfolio Growth Summary & Weekly High Return Stock Forecasts - newser.com
Longeveron secures patent for stem cell therapy targeting aging frailty By Investing.com - Investing.com Nigeria
Longeveron announces resignations of two board members By Investing.com - Investing.com Australia
Longeveron granted U.S. patent for administration of MSCs - TipRanks
How does Longeveron Inc (LGVN) change from a tortoise to a hare? - Setenews
Longeveron secures patent for stem cell therapy targeting aging frailty - Investing.com
Longeveron Granted U.S. Patent for Method of Treating Aging-related Frailty in Patients with Inflammaging Using its Proprietary Stem Cell Therapy - The Manila Times
Longeveron Announces Resignation of Board Members - TipRanks
Longeveron announces resignations of two board members - Investing.com
What analysts say about Longeveron Inc stockMarket Volatility Update & Superior Trading Ideas - earlytimes.in
Can you recover from losses in Longeveron Inc.2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
Analysts Offer Predictions for Longeveron FY2025 Earnings - Defense World
Longeveron Inc Azioni (LGVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Longeveron Inc Azioni (LGVN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Soffer Rock | Director |
May 29 '25 |
Sale |
1.30 |
10,000 |
13,000 |
220,034 |
0.45%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):